AI Health Startup Caresyntax Raises $180M to Bring AI Smarts to the Operating Room

The funding round attracted a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, and several others.
Caresyntax, a leading vendor-neutral precision surgery platform, has announced a significant funding round of $180 million. The financing, which includes a Series C extension and growth debt expansion, comprises $80 million in equity and up to $100 million in growth debt facility. https://twitter.com/caresyntax/status/1824053647111786942?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet The funding round attracted a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, and several others. Caresyntax's platform aims to transform surgery by implementing a scalable, end-to-end software and AI solution. The medical-grade, interoperable platform captures novel
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Abhijeet Adhikari
Abhijeet Adhikari
Abhijeet Adhikari is a Research Associate at AIM-Research, focusing on AI and data science related research reports. Beyond his professional role, Abhijeet is an avid reader with a particular interest in historical and mythological facts, you can reach him at abhijeet.adhikari@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.